Session Details

放射性薬剤1

Thu. Jul 3, 2025 9:45 AM - 10:15 AM JST
Thu. Jul 3, 2025 12:45 AM - 1:15 AM UTC
A(Miraikan Hall)
Chairman:Tomoya Uehara

[2A01-02-01]Basic Assessment for the Development of 211At-labeled Octreotide Derivatives

〇Yuya NEMOTO1, Hiroyuki SUZUKI1, Kento KANNAKA1, Tomoya UEHARA1 (1. Chiba Univ.)

[2A01-02-02]Investigation of the Structure Against Deastatination in Vivo Using Astatobenzoate Moiety

〇Mutsuho Murata1, Sohta Tatsuta1, Kento Kannaka2, Hiroyuki Suzuki2, Kazuhiro Takahashi3, Tomoya Uehara2 (1. Chiba Univ. Phamaceutical Science, 2. Graduate School of Phamaceutical Sciences of Chiba Univ., 3. Fukushima Medical Univ.)